IDO1 has emerged as a new significant therapeutic target due to its indispensable immunomodulatory roles in pregnancy [42], cancer [43], allergy [44] and central nervous system disorders such as Alzheimer’s disease (AD) [45]. This evidence concerns the gene IDO1 and early-onset autosomal dominant Alzheimer disease.